SuperworthXylem XYL
- Market cap
- $25.4B
- PE
- 25.9×
- 10y median 37.5×
- Forward PE
- 18.6×
- 10y median 28.4×
- Price to sales
- 2.8×
- EV/EBIT
- 20.5×
- Revenue, 12 months
- $9.1B
- +5% on a year ago
- Net margin
- 11.2%
- Free cash flow yield
- 3.8%
Xylem trades at 25.9× trailing earnings, cheaper than 95% of the last ten years. Revenue was $9.1B over the last twelve months, up 5% on a year earlier with a 11% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.1B+50% | $2.1B+41% | $2B+40% | $2.2B+26% | $2.1B+1% | $2.3B+7% | $2.1B+2% | $2.3B+6% | $2.3B+8% | $2.4B+6% | $2.1B+3% | $2.3B+2% | |
| Cost of revenue | $1.3B+53% | $1.4B+46% | $1.3B+42% | $1.4B+26% | $1.3B+1% | $1.4B+3% | $1.3B+2% | $1.4B+4% | $1.4B+5% | $1.5B+5% | $1.3B+2% | $1.4B−3% |
| Gross profit | $764M+46% | $756M+32% | $752M+38% | $819M+26% | $784M+3% | $857M+13% | $768M+2% | $892M+9% | $883M+13% | $932M+9% | $803M+5% | $963M+8% |
| R&D | $61M+30% | $60M+11% | $59M+11% | $58M+0% | $55M−10% | $58M−3% | $56M−5% | $58M+0% | $52M−6% | $60M+3% | $56M+0% | $59M+2% |
| SG&A | $491M+67% | $466M+48% | $474M+34% | $485M+9% | $445M−9% | $507M+9% | $460M−3% | $503M+4% | $474M+7% | $486M−4% | $472M+3% | $503M+0% |
| $191M+14% | $211M+7% | $209M+60% | $253M+113% | $280M+47% | $267M+27% | $231M+11% | $305M+21% | $334M+19% | $353M+32% | $244M+6% | $390M+28% | |
| Interest expense | $14M+17% | $14M+8% | $14M+56% | $11M−8% | $10M−29% | $9M−36% | $8M−43% | $9M−18% | $6M−40% | $6M−33% | $4M−50% | $7M−22% |
| Pre-tax income | $185M+988% | $210M+11% | $196M+56% | $247M+117% | $269M+45% | $375M+79% | $217M+11% | $299M+21% | $297M+10% | $368M−2% | $244M+12% | $364M+22% |
| $33M+560% | −$56M | $43M+59% | $53M+141% | $52M+58% | $49M | $50M+16% | $75M+42% | $71M+37% | $35M−29% | $55M+10% | $103M+37% | |
| Net income | $152M+1167% | $266M+79% | $153M+55% | $194M+111% | $217M+43% | $326M+23% | $169M+11% | $226M+17% | $227M+5% | $335M+3% | $193M+14% | $263M+16% |
| $0.63+800% | $1.10+34% | $0.63+17% | $0.80+78% | $0.89+41% | $1.34+22% | $0.69+10% | $0.93+16% | $0.93+5% | $1.37+2% | $0.79+15% | $1.11+19% | |
| 242.2M+34% | 242.2M+34% | 243M+34% | 243.5M+18% | 243.8M+1% | 243.8M+1% | 243.8M+0% | 243.9M+0% | 244.1M+0% | 244.2M+0% | 243.4M−0% | 236.6M−3% |
Interest expense: Q1 FY11: 6 months less the 3 months printed beside them.
EPS, diluted: 7 periods, Q4 FY11 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY11: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution. 14 periods, Q4 FY12 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $2.3B | $2.2B to $2.3B | $1.45 | $1.43 to $1.51 | 12 |
| Q4 FY26 | $2.4B | $2.4B to $2.5B | $1.64 | $1.55 to $1.71 | 12 |
| Q1 FY27 | $2.2B | $2.2B to $2.2B | $1.20 | $1.18 to $1.23 | 5 |
| Q2 FY27 | $2.4B | $2.4B to $2.5B | $1.56 | $1.53 to $1.59 | 5 |
| Q3 FY27 | $2.4B | $2.4B to $2.5B | $1.59 | $1.56 to $1.63 | 5 |
| Q4 FY27 | $2.6B | $2.5B to $2.6B | $1.81 | $1.78 to $1.86 | 5 |
| Q1 FY28 | $2.3B | $2.3B to $2.4B | $1.39 | $1.36 to $1.42 | 6 |
| Q2 FY28 | $2.6B | $2.5B to $2.6B | $1.80 | $1.77 to $1.84 | 6 |
Peers
Companies in Industrial - Machinery nearest Xylem's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| XYLXylem | $25.4B | 25.9× | 37.5× | 18.6× | 2.8× | +5% | 11.2% |
| DOVDover | $26.8B | 24.0× | 19.2× | 17.7× | 3.2× | +8% | 13.5% |
| SYMSymbotic | $23.8B | 436× | 467× | 110× | 9.0× | +21% | 0.5% |
| IRIngersoll Rand | $28.5B | 30.2× | 39.8× | 19.6× | 3.6× | +8% | 12.1% |
| OTISOtis Worldwide | $28.6B | 19.3× | 26.4× | 17.5× | 1.9× | +5% | 10.2% |
| NDSNNordson | $17.8B | 32.2× | 27.5× | n/m | 6.0× | +7% | 18.6% |
| ITTITT | $17B | 37.3× | 22.4× | n/m | 3.6× | +28% | 8.9% |
| IEXIDEX | $16.9B | 32.9× | 30.1× | n/m | 4.7× | +7% | 14.5% |
| RBCRBC Bearings INC | $14.9B | 46.6× | 41.0× | n/m | 7.6× | +17% | 16.4% |
| LECOLincoln Electric | $14B | 25.6× | 24.7× | n/m | 3.1× | +9% | 12.4% |
| CARRCarrier Global | $46.4B | 39.1× | 18.8× | 18.6× | 2.1× | −2% | 5.5% |
| Peer median | $20.8B | 32.6× | 27.0× | 18.6× | 3.6× | +8% | 12.2% |
More on Xylem
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #9of 200Industrial stocks cheapest against their own PE history
- #4of 46Industrial machinery stocks cheapest against their own PE history
- #5of 14Industrial machinery stocks with the lowest forward PE
- #6of 13Industrial machinery stocks with the highest dividend yields
- #8of 13Industrial machinery stocks with the lowest PEG ratio
Its groups
About
- Industry
- Industrial - Machinery
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .